GB9904163D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number: GB9904163D0
Authority: GB; United Kingdom
Prior art keywords: pharmaceutical compositions; pharmaceutical; compositions
Prior art date: 1999-02-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB9904163.4A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bioglan Laboratories Ltd

Original Assignee

Bioglan Laboratories Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-23

Filing date

1999-02-23

Publication date

1999-04-14

1999-02-23 Application filed by Bioglan Laboratories Ltd filed Critical Bioglan Laboratories Ltd

1999-02-23 Priority to GBGB9904163.4A priority Critical patent/GB9904163D0/en

1999-04-14 Publication of GB9904163D0 publication Critical patent/GB9904163D0/en

2000-02-23 Priority to IL14451100A priority patent/IL144511A0/en

2000-02-23 Priority to EP00905198A priority patent/EP1152754A1/en

2000-02-23 Priority to BR0008402-6A priority patent/BR0008402A/en

2000-02-23 Priority to PCT/GB2000/000640 priority patent/WO2000050025A1/en

2000-02-23 Priority to HU0200061A priority patent/HUP0200061A2/en

2000-02-23 Priority to AU26825/00A priority patent/AU2682500A/en

2000-02-23 Priority to CA002362564A priority patent/CA2362564A1/en

2000-02-23 Priority to JP2000600637A priority patent/JP2002537330A/en

Status Ceased legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

GBGB9904163.4A 1999-02-23 1999-02-23 Pharmaceutical compositions Ceased GB9904163D0 (en)

Priority Applications (9)

Application Number	Priority Date	Filing Date	Title
GBGB9904163.4A GB9904163D0 (en)	1999-02-23	1999-02-23	Pharmaceutical compositions
IL14451100A IL144511A0 (en)	1999-02-23	2000-02-23	Topic tricyclic antidepressants as analgesics
EP00905198A EP1152754A1 (en)	1999-02-23	2000-02-23	Topic tricyclic antidepressants as analgesics
BR0008402-6A BR0008402A (en)	1999-02-23	2000-02-23	Uses of doxepine, doxepine hydrochloride or a metabolite of doxepine or doxepine hydrochloride, and of a tca, pharmaceutical composition, methods to provide an analgesic treatment, and to improve deep localized or internal pain
PCT/GB2000/000640 WO2000050025A1 (en)	1999-02-23	2000-02-23	Topic tricyclic antidepressants as analgesics
HU0200061A HUP0200061A2 (en)	1999-02-23	2000-02-23	Topic tricyclic antidepressants as analgesics
AU26825/00A AU2682500A (en)	1999-02-23	2000-02-23	Topic tricyclic antidepressants as analgesics
CA002362564A CA2362564A1 (en)	1999-02-23	2000-02-23	Topic tricyclic antidepressants as analgesics
JP2000600637A JP2002537330A (en)	1999-02-23	2000-02-23	Topical tricyclic antidepressant as an analgesic

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9904163.4A GB9904163D0 (en)	1999-02-23	1999-02-23	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
GB9904163D0 true GB9904163D0 (en)	1999-04-14

Family

ID=10848352

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB9904163.4A Ceased GB9904163D0 (en)	1999-02-23	1999-02-23	Pharmaceutical compositions

Country Status (9)

Country	Link
EP (1)	EP1152754A1 (en)
JP (1)	JP2002537330A (en)
AU (1)	AU2682500A (en)
BR (1)	BR0008402A (en)
CA (1)	CA2362564A1 (en)
GB (1)	GB9904163D0 (en)
HU (1)	HUP0200061A2 (en)
IL (1)	IL144511A0 (en)
WO (1)	WO2000050025A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6284797B1 (en) *	1999-04-12	2001-09-04	Donald A. Rhodes	Topical treatment of pain and to promote healing
DK1395289T3 (en) *	2001-06-07	2011-03-28	Christine Dr Sang	Treatment of neuropathic pain with an N-methyl-D-aspartate (NMDA) receptor antagonist
US6638981B2 (en) *	2001-08-17	2003-10-28	Epicept Corporation	Topical compositions and methods for treating pain
WO2004056305A2 (en)	2002-12-18	2004-07-08	Algorx	Administration of capsaicinoids
JP2006513267A (en)	2002-12-18	2006-04-20	アルゴルクスファーマスーティカルズ，インク	Capsaicinoid administration
US20050176809A1 (en) *	2004-02-05	2005-08-11	Rodlen Laboratories, Inc.	Method and compositions for treatment of painful disorders
WO2007049825A1 (en) *	2005-10-28	2007-05-03	Kyushu University, National University Corporation	P2x4 receptor antagonist
US20100179214A1 (en)	2006-05-19	2010-07-15	Somaxon Pharmaceuticals, Inc.	Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders
CA2687118A1 (en)	2006-05-19	2007-12-13	Somaxon Pharmaceuticals, Inc.	Methods of using low-dose doxepin for the improvement of sleep
US20080058408A1 (en)	2006-05-19	2008-03-06	Rogowski Roberta L	Low-dose doxepin for treatment of sleep disorders in elderly patients
US20100227916A1 (en) *	2006-05-19	2010-09-09	Somaxon Pharmaceuticals, Inc	N-desmethyl-doxepin and methods of using the same to treat sleep disorders
US20100179215A1 (en)	2006-05-19	2010-07-15	Somaxon Pharmaceuticals, Inc.	Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders
WO2008011150A1 (en)	2006-07-20	2008-01-24	Somaxon Pharmaceuticals, Inc.	Methods of improving the pharmacokinetics of doxepin
US20100105614A1 (en)	2006-10-25	2010-04-29	Somaxon Pharmaceuticals, Inc.	Ultra low dose doxepin and methods of using the same to treat sleep disorders
WO2008070795A2 (en)	2006-12-06	2008-06-12	Somaxon Pharmaceuticals, Inc.	Combination therapy using low-dose doxepin for the improvement of sleep
WO2008128115A2 (en)	2007-04-13	2008-10-23	Somaxon Pharmaceuticals, Inc.	Low-dose doxepin formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5008289A (en) *	1988-12-02	1991-04-16	Galenpharma, Inc.	Composition for treating nasal disorders and headaches
US6197830B1 (en) *	1995-09-22	2001-03-06	Bruce M. Frome	Method for achieving relief from sympathetically mediated pain
US6211171B1 (en) *	1998-05-19	2001-04-03	Dalhousie University	Use of antidepressants for local analgesia

1999
- 1999-02-23 GB GBGB9904163.4A patent/GB9904163D0/en not_active Ceased
2000
- 2000-02-23 JP JP2000600637A patent/JP2002537330A/en not_active Withdrawn
- 2000-02-23 CA CA002362564A patent/CA2362564A1/en not_active Abandoned
- 2000-02-23 HU HU0200061A patent/HUP0200061A2/en unknown
- 2000-02-23 EP EP00905198A patent/EP1152754A1/en not_active Withdrawn
- 2000-02-23 BR BR0008402-6A patent/BR0008402A/en not_active Application Discontinuation
- 2000-02-23 AU AU26825/00A patent/AU2682500A/en not_active Abandoned
- 2000-02-23 IL IL14451100A patent/IL144511A0/en unknown
- 2000-02-23 WO PCT/GB2000/000640 patent/WO2000050025A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
BR0008402A (en)	2002-01-29
EP1152754A1 (en)	2001-11-14
AU2682500A (en)	2000-09-14
HUP0200061A2 (en)	2002-06-29
IL144511A0 (en)	2002-05-23
JP2002537330A (en)	2002-11-05
CA2362564A1 (en)	2000-08-31
WO2000050025A1 (en)	2000-08-31

Legal Events

Date	Code	Title	Description
2000-05-17	AT	Applications terminated before publication under section 16(1)

Publication	Publication Date	Title
HUP0202513A3 (en)	2004-06-28	Betha-carboline pharmaceutical compositions
GB0028088D0 (en)	2001-01-03	Pharmaceutical compositions
GB0001662D0 (en)	2000-03-15	Pharmaceutical compositions
PL351387A1 (en)	2003-04-07	Pharmaceutical composition
HU9901606D0 (en)	1999-07-28	Pharmaceutical compositions
HK1044476A1 (en)	2002-10-25	Medicinal compositions
GB9827996D0 (en)	1999-02-10	Pharmaceutical Compositions
HUP0103507A3 (en)	2002-05-28	Pharmaceutical compositions comprising 2-quinolones
GB9923436D0 (en)	1999-12-08	Pharmaceutical compositions
EP1166786A4 (en)	2004-05-12	Medicinal compositions
AU3556400A (en)	2000-10-04	Pharmaceutical compositions
GB9904163D0 (en)	1999-04-14	Pharmaceutical compositions
GB9809213D0 (en)	1998-07-01	Pharmaceutical compositions
GB9911017D0 (en)	1999-07-14	Pharmaceutical compositions
AU6460200A (en)	2001-03-13	Pharmaceutical compositions
IL137403A0 (en)	2001-07-24	Pharmaceutical compositions
GB9904911D0 (en)	1999-04-28	Pharmaceutical compositions
AU6460100A (en)	2001-03-13	Pharmaceutical compositions
GB9902651D0 (en)	1999-03-31	Pharmaceutical compositions
IL130325A0 (en)	2000-06-01	Pharmaceutical compositions comprising allicin
GB9806487D0 (en)	1998-05-27	Pharmaceutical compositions
GB9920652D0 (en)	1999-11-03	Pharmaceutical compositions
GB9902594D0 (en)	1999-03-24	Pharmaceutical compositions
GB9902591D0 (en)	1999-03-24	Pharmaceutical compositions
GB9916413D0 (en)	1999-09-15	Pharmaceutical composition